Form 4: Quantum-Si CEO Executes Mandatory Tax-Related Share Sale

CEO Jeffrey Alan Hawkins sold a total of 167,424 shares of Quantum-Si Class A Common Stock to satisfy mandatory tax withholding obligations.

Summary

• CEO Jeffrey Alan Hawkins sold 83,712 shares on April 20, 2026, at a weighted average price of $1.0064.
• CEO Jeffrey Alan Hawkins sold an additional 83,712 shares on April 21, 2026, at a weighted average price of $0.995.
• The transactions were conducted under a mandatory sell-to-cover provision to satisfy tax withholding requirements related to the vesting of restricted stock units.
• Following these transactions, the CEO retains beneficial ownership of 3,692,423 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the share sale was purely administrative and mandatory to satisfy tax obligations rather than a discretionary divestment.

Positives

• The sale was non-discretionary and mandated by the company's tax withholding policy, indicating no change in management's long-term outlook or confidence in the company.

Negatives

• The reduction in the CEO's direct shareholding, although mandatory, decreases the total equity stake held by the executive.

Risks

• Continued downward pressure on share price could impact the value of remaining equity holdings for management and shareholders.

Future Outlook

No forward-looking guidance or strategic updates were provided in this filing.

Management Comments

• The filing notes that the individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award.

Industry Context

StockSavvy.ai notes that mandatory sell-to-cover transactions are standard corporate governance practices for executives to manage tax liabilities upon the vesting of equity awards and do not typically signal a change in corporate strategy or executive sentiment.

Comparison to Industry Standards

• The use of mandatory sell-to-cover provisions is a standard practice among publicly traded biotechnology and life sciences companies to ensure compliance with tax regulations during RSU vesting cycles.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a pre-planned, mandatory tax-related event.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Quantum-Si, QSI, Insider Trading, Form 4, Executive Compensation, Tax Withholding